Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their efficacy and safety.
Related Posts
Microsoft says Google is running ‘shadow campaigns’ in Europe to influence regulators
Microsoft suggested Google has a pattern of funding organizations with the mission of discrediting the software company with regulators.
Eli Lilly’s Zepbound causes greater weight loss than Novo Nordisk’s Wegovy in head-to-head trial
Zepbound’s greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss […]
Trump’s next Fed chair pick already comes with a credibility problem
If leading the Federal Reserve isn’t challenging enough, the next central bank chair will face an additional burden.